Efficacy and safety of Gelsectan for diarrhoea-predominant irritable bowel syndrome: A randomised, crossover clinical trial.
United European Gastroenterol J
; 7(8): 1093-1101, 2019 10.
Article
in En
| MEDLINE
| ID: mdl-31662866
Key words
Full text:
1
Database:
MEDLINE
Therapeutic Methods and Therapies TCIM:
Plantas_medicinales
Main subject:
Oligosaccharides
/
Xylans
/
Irritable Bowel Syndrome
/
Diarrhea
/
Demulcents
/
Pea Proteins
/
Glucans
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
Country/Region as subject:
Europa
Language:
En
Journal:
United European Gastroenterol J
Year:
2019
Type:
Article
Affiliation country:
Romania